Read more
Informationen zum Autor Dr Karen Schreiber main clinical and research interests are antiphospholipid syndrome and connective tissue diseases in pregnant women. Dr Schreiber is involved in identifying alternative treatment to improve fetal and maternal pregnancy outcomes in pregnant women with antiphospholipid syndrome. Dr Schreiber is an active member of the British Society for Rheumatology (BSR) working groups publishing clinical guidelines with the overall aim to improve the treatment of patients with rheumatic diseases.Dr. Chakravarty is a rheumatologist and epidemiologist with a longstanding clinical and research interest in understanding the interrelationships between pregnancy and underlying rheumatic diseases. She works to identify and mitigate risk factors for adverse pregnancy outcomes and to optimize medical management of chronic rheumatic diseases during pregnancy and the postpartum period in order to maximize outcomes for both mother and infant.Dr. Østensen is a rheumatologist with a special interest in the interaction between pregnancy and the rheumatic diseases. Her research through many years has focussed on reproduction issues of women and men with rheumatic disease; immunology of pregnancy; antirheumatic drugs during pregnancy and breastfeeding. She has established specialized centers at Rheumatology departments in Norway and in Switzerland that counsel and manage patients who plan a family or are pregnant. Klappentext A collection of 70 cases covering pregnancy counselling, the management of disease flares, thromboembolic disease, the management of patients with end organ disease, advice on medications, obstetric complications, infections and the management of rare diseases in women with rheumatic diseases before and during pregnancy as well as post-partum. Zusammenfassung A collection of 70 cases covering pregnancy counselling, the management of disease flares, thromboembolic disease, the management of patients with end organ disease, advice on medications, obstetric complications, infections and the management of rare diseases in women with rheumatic diseases before and during pregnancy as well as post-partum. Inhaltsverzeichnis Section One: Counselling 1: Monika Østensen: Important points of pre-pregnancy counselling Section Two: Patients with pre-pregnancy complications 2.1: Andrew James Doyle and Beverley Jane Hunt: Thrombotic Complications in pregnant patients with rheumatic disease 2.2: Roseann O'Doherty and Fionnuala Ní Ainle: Prevention of postpartum venous thromboembolism (VTE) 2.3: Eliza Chakravarty: Pulmonary Arterial Hypertension 2.4: Hannah Blakey and Kate Bramham: Advanced renal disease / renal impairment 2.5: Massimo Radin, Karen Schreiber, and Savino Sciascia: Antibodies as risk factors for adverse maternal and fetal outcomes Section Three: Adjustment of therapy before/during pregnancy and lactation 3.1: Monika Østensen and Ian Giles: Disease modifying drugs, biological drugs and concomitant medications before/during pregnancy and lactation 3.2: Christof Schaefer: Managing a patient exposed to a teratogenic drug at different stages of pregnancy Section Four: Infection during pregnancy 4: Maria Rhona G. Bergantin and Sandra V. Navarra: Infection in a pregnant patient on immunosuppressive treatment Section Five: Organ specific flares during pregnancy 5: Bonnie L. Bermas and Eliza Chakravarty: Managing Organ Specific Flares Section Six: Obstetric complications in women with autoimmune diseases 6: D. Ware Branch: Pregnancy and Obstetric Complications in Women with Autoimmune Diseases Section Seven: Vaccination before or during pregnancy 7: Cara D Varley and Kevin L Winthrop: Vaccination before or during pregnancy Section Eight: Rare diseases in pregnancy 8.1: Karen Schreiber and Monika Ostensen: SLE 8.2: Karen Schreiber and Soeren Jacobsen: Systemic lupus erythematosus ...
